this article has been archived; content may be out of date.
#e4pMCM: the best bits from Twitter
|18th September 2014
The eyeforpharma Multichannel Marketing Summit, held at Victoria Park Plaza hotel, brought together pharma's marketing community who were all keen to learn how to enhance their current multichannel strategy. We've been following #e4pMCM to bring you the best bits of the conference, as it happened on Twitter:
Bert van Eijk @Boehringer talks #multichannel#marketing & #oncology#cancer@eyeforpharma#e4pMCM#e4pVASpic.twitter.com/BDtdB2kThu — PharmaTelevision (@PharmaTV) September 17, 2014Join it all together so that you can make decisions based on the evidence. #e4pmcmpic.twitter.com/yKwTZGWeYo — Wilf ILIFFE (@wilf66) September 17, 2014
People still think bad pharma, but there is opportunity to build trust using digital data. Context and strategy is crucial, hears #e4pMCM — Selina McKee (@PTSelinaMcKee) September 17, 2014#e4pmcm@SusSchaeffer pointing out we hide behind regulation. Eg. In SM listening — Kay Wesley (@KayWesley) September 18, 2014Chris Metzger says "Your desk is the worst place from which to view the world" - totally agree #e4pMCM — Beth Moore (@BethLMoore) September 18, 2014Ben from @bmorecreative24 discussing (and wearing!) how google glass & wearable tech will change healthcare #e4pMCMpic.twitter.com/ddqiTU7ksY — Polly Lutter (@polwar13) September 17, 2014Interesting that GPs are looking for similar information/capabilities in different places. Some inefficiencies being discussed. #e4pMCM — Gareth Dabbs (@garethdabbs) September 18, 2014A key way patients make decisions about their therapies is by talking to each other #e4pMCM — ThePharmaLetter (@ThePharmaLetter) September 18, 2014"If it's not improving the experience why are we doing it?" says @PharmaCXM. Great question #e4pMCM — Rebecca Belton (@beckybelton) September 17, 2014GP says 'I'm a human being not a segment'-be open & transparent,allow us to be professionals & balance risks & benefits #e4pMCM — Julie O'Donnell (@julieodonn) September 18, 2014Best session yet - 2 UK GPs talking about value of reps, digital, MCM: "focus on confidence transfer - not how great your drug is" #e4pMCM — Polly Lutter (@polwar13) September 18, 2014#e4pmcm iPad detailing cannot replace experience and knowledge from reps - just being there to navigate the slides is not the way forward. — Chris Wade (@wadoinlondon) September 18, 2014'Why can't I speak to the person who knows most about the medication' very true. #e4pMCM — Gareth Dabbs (@garethdabbs) September 18, 2014Another wow experience here at #e4pMCM: pfizer showing results from remote rep project! Go figure!! pic.twitter.com/8Lg6dMPpBX — Susanne Schäffer (@SusSchaeffer) September 17, 2014Patient panel: it doesn't matter thru what channel we communicate - we have try the patients shoes #e4pMCM — Nataliya Andreychuk (@nataliaand) September 18, 2014There's no denying that the main topic for discussion at the conference was around patient-centricity and the importance of finding out what is it that your customer needs, before designing a product or service for them.
If you’d like to discuss how we can help you meet your own challenges, call us on +44 203 328 1840 or contact us via email at hello@bluelatitude.com.
Mobilising the public to combat the antimicrobial resistance crisis
|11th January 2019
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines this issue and explores what we could do to spark behaviour change.
Q&A with Dr Timothy Vollmer, leading MS Neurologist
|11th December 2018
Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.
Report: Achieving launch excellence in the challenging healthcare markets of today
|10th December 2018
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging markets.